Skip to main content
Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
105.35
+0.36 (0.34%)
At close: Nov 13, 2026, 4:00 PM EST
106.15
+0.80 (0.76%)
After-hours: Nov 13, 2026, 7:30 PM EST

Oruka Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Cash & Equivalents
191.5246.9461.58
Short-Term Investments
728.76290.11314.07
Cash & Short-Term Investments
920.28337.04375.65
Cash Growth
163.57%-10.28%-
Prepaid Expenses
21.226.811.22
Total Current Assets
941.49343.86376.87
Property, Plant & Equipment
3.12.121.04
Long-Term Investments
286.31142.5418.07
Other Long-Term Assets
0.130.10.04
Total Assets
1,231488.62396.02

Liabilities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Accounts Payable
14.384.163.46
Accrued Expenses
16.5710.69.37
Current Portion of Leases
0.840.620.21
Total Current Liabilities
31.7815.3713.04
Long-Term Leases
2.091.310.76
Total Liabilities
33.8816.6913.8

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Common Stock
0.070.050.04
Additional Paid-In Capital
1,512657.56463.02
Retained Earnings
-312.15-189.16-83.72
Comprehensive Income & Other
-5.040.55-0.04
Total Common Equity
1,195469379.29
Shareholders' Equity
1,197471.93382.22
Total Liabilities & Equity
1,231488.62396.02

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Total Debt
2.931.930.97
Net Cash (Debt)
1,204477.65392.75
Net Cash Growth
141.21%21.62%-
Net Cash Per Share
19.7010.4723.39
Filing Date Shares Outstanding
67.8249.5437.44
Total Common Shares Outstanding
67.2348.7237.44
Working Capital
909.71328.48363.83
Book Value Per Share
17.789.6310.13
Tangible Book Value
1,195469379.29
Tangible Book Value Per Share
17.789.6310.13
SEC Filings: 10-K · 10-Q